These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 129004)

  • 21. Hepatitis B infection in institutionalized Down's syndrome inmates: a longitudinal study with five hepatitis B virus markers.
    Hawkes RA; Boughton CR; Schroeter DR; Decker RH; Overby LR
    Clin Exp Immunol; 1980 Jun; 40(3):478-86. PubMed ID: 6448112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and distribution of hemagglutinating antibody against the hepatitis B antigen in institutionalized populations.
    Szmuness W; Prince AM; Etling GF; Pick R
    J Infect Dis; 1972 Nov; 126(5):498-506. PubMed ID: 4268554
    [No Abstract]   [Full Text] [Related]  

  • 23. Down's syndrome and hepatitis: an evaluation of carrier status.
    Dicks JL; Dennis ES
    J Am Dent Assoc; 1987 May; 114(5):637-9. PubMed ID: 2955013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis A and B in non-institutionalized mentally retarded patients.
    Renner F; Andrle M; Horak W; Rett A
    Hepatogastroenterology; 1985 Aug; 32(4):175-7. PubMed ID: 2932380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B in a Belgian institution for mentally retarded patients: an epidemiological study.
    Devuyst O; Maesen-Collard Y
    Acta Gastroenterol Belg; 1991; 54(1):12-8. PubMed ID: 2058345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis-B surface antigen and antibody: prevalence and persistence in institutionalized and noninstitutionalized persons.
    McMillan BC; Hanson RP; Golubjatnikov R; Sinha SK
    Public Health Rep; 1979 Jun; 94(3):262-7. PubMed ID: 156381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B in the non-residential mentally handicapped population.
    Devlin JB; Mulcahy M; Corcoran R; Ramsay L; Tyndall P; Shattock A
    J Intellect Disabil Res; 1993 Dec; 37 ( Pt 6)():553-60. PubMed ID: 8124001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intradermal hepatitis B vaccination for mentally retarded patients.
    Hayashi J; Kashiwagi S; Noguchi A; Nakashima K; Ikematsu H; Kajiyama W
    J Infect; 1989 Sep; 19(2):119-25. PubMed ID: 2530288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B surface antigen and its subtypes in an institution for the mentally retarded.
    Perry E; Chaudhary RK; Cleary TE; Roughley FR
    Can Med Assoc J; 1975 Jan; 112(1):46-8. PubMed ID: 122813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long term observation of the effect of intradermal hepatitis B vaccination on mentally retarded patients.
    Hayashi J; Noguchi A; Nakashima K; Morofuji M; Kashiwagi S
    Eur J Epidemiol; 1991 Nov; 7(6):649-53. PubMed ID: 1838338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of hepatitis A in an institution for the mentally retarded in an intermediate endemicity area: influence of age length of institutionalization.
    Gil A; González A; Dal-Ré R; Dominguez V; Ortega P; Barrio JL; Aguilar L
    J Infect; 1999 Mar; 38(2):120-3. PubMed ID: 10342653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B e antigen and antibody measured by radioimmunoassay in acute hepatitis B surface antigen-positive hepatitis.
    Aldershvile J; Frösner GG; Nielsen JO; Hardt F; Deinhardt F; Skinhøj P
    J Infect Dis; 1980 Mar; 141(3):293-8. PubMed ID: 7365280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prevalence of serological markers, hepatitis B virus DNA and elevated serum amino transferase values in institutionalized mentally handicapped males and females: an epidemiological study of HBV infection in residents with Down's syndrome or other forms of mental deficiency.
    van Ditzhuijsen TJ; Kleijnen FM; Rijntjes PJ; van Loon AM; Yap SH
    Eur J Epidemiol; 1988 Sep; 4(3):349-56. PubMed ID: 2972557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B in seven hospitals for the mentally handicapped.
    Clarke SK; Caul EO; Jancar J; Gordon-Russell JB
    J Infect; 1984 Jan; 8(1):34-43. PubMed ID: 6230404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Australia antigen, autoantibodies and cell-mediated immune responses in patients with Down's syndrome.
    Campion EC; Wangel AG
    Med J Aust; 1975 Apr; 01(15):468-70. PubMed ID: 125374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occurrence of Australia antigen in patients with Down's syndrome in Poland.
    Zdzienicka E; Kacperska E
    J Ment Defic Res; 1971 Mar; 15(1):30-7. PubMed ID: 4253115
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunogenicity of a recombinant DNA hepatitis B vaccine in institutionalized patients with Down's syndrome.
    Van Damme P; Vranckx R; Meheus A
    Vaccine; 1990 Mar; 8 Suppl():S53-5; discussion S60-2. PubMed ID: 2139285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prevalence of hepatitis B infection in institutions for the mentally retarded. Epidemiologic characteristics in the province of Vizcaya].
    Aristegui Fernández J; Cisterna Cáncer R; Muñiz Saitua J; Gorostiza E; Pérez Legorburu A; Cos Arregui B; Delgado Rubio A
    Med Clin (Barc); 1989 Mar; 92(9):323-7. PubMed ID: 2716426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Occurrence of hepatitis B and C among mentally retarded].
    Lunding S; Hansen KS; Krogsgaard K; Rosdahl N; Smith E; Wantzin PS
    Ugeskr Laeger; 1999 Aug; 161(31):4393-6. PubMed ID: 10487103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different operating conditions affect risk of hepatitis B virus infection at two residential institutions for the mentally disabled.
    Perrillo RP; Strang S; Lowry OH
    Am J Epidemiol; 1986 Apr; 123(4):690-8. PubMed ID: 3953548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.